Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
£25K is f*ck all to those who will want to use it - big pharma etc,.
Dr A
I am anxious, probably for no good reason and I seek reassurance. We have HUI about to list, and aiming to have their DMG up and running before the PROTOS original (2022 vs 2023). HUI is showing a great deal more energy than PHE. They are using major european suppliers to make the most important parts of the DMG, and i do not doubt they will do it well, and without delays the like of which PHE has endured. Is there any chance they may ultimately get around whatever Patents PHE have, and aim to set up a parallel DMG system as a competitor?
Overall I find it bizarre that HUI will be up and running before PHE, and a sad indictment of PHE's reliance and trust in Peel
Sense
The rerate will surely have to wait until it is demonstrated that DMG works 'as it says on the tin'. I would love it to be earlier but just don't think it will happen. The events of the last few weeks have put a dampener on this stock and it will take credible progress for this to change.
Bast
You may be right, but there surely has to be a large amount of testing of the full size DMG at Protos before the unit(s) in Poland can become functional. Yeo said as much in one of his last RNS - testing individually for electricity output, and hydrogen output etc,. With kit that works at very high temperatures i would, as a buyer, want to be certain there were no issues with corrosion with prolonged use.
Pablo
Good post. In the circumstances, how ever did PHE end up with this man as Exec chairman? Seems extraordinary that his track record was not known. He was promoted from Director to Vice Chairman almost exactly one year ago. Good riddance. It was a mistake, but whether it caused long term damage to PHE is not clear to me.
Either devastating personal news - health, and the need for someimmediate agressive treatment - or he was pushed. To go while negotiations for a new CEO were in progress is precipitate, to say the least. SP has gone in the wrong direction on this news. Whatever the reason it is in the best interests of PHE.
To have a cell that is pristine, and not affected by an antibody stuck to it is of great importance in subsequent anayses of cell surface antigens. It is highly likely to become the go-to test in cancer studies primarily in relation to tailoring of treatments - all of which are bl**dy expensive- and are wasted at present on a try and see basis. This gives false hope to the patient as well, which is not desirable.
Markops
Your second para sums up the problem. The reasons for a greater than 12 month delay have not been explained, and what little explanation there was comes from someone whose track record in telling the truth has been exposed in court. [Would you buy a used car etc,.etc?.] It is only understandable that investors will have serious misgivings about PHE. I fear PHE will lag sub 3p until verifiable news appears, which may be 12 months away. I am a rather reluctant holder now.
Sangi
Interesting article - and numerous leads from it. As far as I am aware, all these other guys are using analyses based on cell free DNA, ie degenerate fragments of DNA from dead cancer cells. Parsortix provides the real thing: intact cancer cells, (with complete strands of DNA etc,.) which have required no antigenic manipulation (epitope independent is the term I think) in order to isolate them. So what Parsortix has achieved is isolation of 'pure' unaltered cancer cells from the circulation. This is a first, and has far more potential than Grail, Guardant etc,.as a companion to management of solid tumours
!Leo
2/2 meaning 2nd Feb - but which year? The announcement to be interpreted as: ' We had had a bunch of navvies with a digger to come and clear the site, and make a hole in the fence'. Since when SFA,
I no longer believe anything this shower put out. By the time DMG is up and running (if ever) it certainly will not be FOAK, perhaps LOAK?
This reminds me of another share that had huge potential - Avanti - that the brokers were quoting a target of £20 plus. It hit £7.30, and the fell, inexorably, to 1p through mismanagement. FOAK will not even be SOAK or TOAK here at this rate, if you get my meaning.
And where is the rebound we were told about last night?
Deeply p!ssed off.
There is too much in Yeo's statement that is evasive. What is the new hold up? Is it finance?, Is it difficulty obtaining specialist parts? Is it Peel p*ssing about for reasons best known to themselves? His statement reflects his background as a (slippery) politician. I am far less prepared to be forgiving of this man than others. Time will tell who is right